Arabic Arabic English English French French German German
dark

Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status

At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772 Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Cancer Research UK reports ‘most successful financial year’ for its spinouts

Next Post

Galapagos reports early clinical results for SIK inhibitor

Related Posts
Total
0
Share